| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Jerel Davis is a Director, 10% Owner at LENZ Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 6 sells.
Estimated insider holdings value: $118.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | RPTX Repare Therapeutics Inc. | Director | Sell | 250,000 | $16.00 | $4,000,000.00 | -10.7% | -34.7% | -59.6% | |
| Jun 3, 2022 | RPTX Repare Therapeutics Inc. | Director, 10% Owner | Sell | 750,000 | $12.25 | $9,188,775.00 | -15.7% | -4.4% | -13.0% | |
| Jun 29, 2021 | LENZ Lenz Therapeutics, Inc. | Director, 10% Owner | Buy | 180,000 | $17.00 | $3,060,000.00 | +11.8% | -39.1% | -89.9% | |
| Jun 23, 2020 | RPTX Repare Therapeutics Inc. | Director | Buy | 250,000 | $20.00 | $5,000,000.00 | +6.6% | - | - |